The effect of chemotherapy on lymphocyte subpopulations and cell-mediated cytotoxicity in patients with ovarian carcinoma.
Chemotherapy using adriamycin with cyclophosphamide, and cyclophosphamide with hexamethylmelamine or with alkeran causes no significant reduction in the total lymphocyte count, in the percentage subpopulations of T cells and B cells or in mononuclear cell cytotoxicity in patients with Stage II carcinoma of the ovary during their first course of chemotherapy.